Sign In
Buy IDXX
$595.76
+9.09 (+1.55%)
At Close: Aug 10, 2026
IDEXX Expands Catalyst Platform into Cardiac Disease with First and Only Dual-Species Point-of-Care NT-proBNP Test
07:00am, Tuesday, 11'th Aug 2026
WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX announces Catalyst™ proBNP Test, the first and only dual-species, in-clinic diagnostic assay for cardiac assessment.
IDEXX Laboratories: Worth The Premium
08:00am, Saturday, 08'th Aug 2026
IDEXX Laboratories remains a buy, supported by a durable moat, strong recurring revenue, and a long-term international growth runway. Recent Q2 2026 results showed 9% organic revenue growth, EPS guida
Aurora Investment Managers LLC. Makes New Investment in IDEXX Laboratories, Inc. $IDXX
04:03am, Saturday, 08'th Aug 2026
Aurora Investment Managers LLC. bought a new stake in IDEXX Laboratories, Inc. (NASDAQ: IDXX) in the undefined quarter, according to the company in its most recent filing with the Securities and Excha
Here is Why Growth Investors Should Buy Idexx (IDXX) Now
01:46pm, Thursday, 06'th Aug 2026
Idexx (IDXX) could produce exceptional returns because of its solid growth attributes.
IDEXX Laboratories, Inc. $IDXX Shares Sold by Empowered Funds LLC
04:14am, Thursday, 06'th Aug 2026
Empowered Funds LLC cut its position in IDEXX Laboratories, Inc. (NASDAQ: IDXX) by 65.7% during the undefined quarter, according to the company in its most recent filing with the Securities and Exchan
IDEXX Laboratories Q2 Earnings Call Highlights
03:09am, Thursday, 06'th Aug 2026
IDEXX Laboratories (NASDAQ: IDXX) reported second-quarter 2026 revenue growth of approximately 10% on a reported basis and 9% organically, driven by companion animal diagnostics, water and livestock,
Revenue: Increased approximately 10% as reported and 9% organically.CAG Diagnostics Recurring Revenue: Grew 10.3% organically, with double-digit gains in both t
IDXX Q2 Earnings & Revenues Beat, '26 EPS View Up, Stock Up in Pre-Market
12:51pm, Tuesday, 04'th Aug 2026
IDEXX Laboratories beats Q2 estimates, expands margins and raises its 2026 EPS outlook as diagnostics demand and adoption fuel growth.
IDEXX Laboratories, Inc. (IDXX) Q2 2026 Earnings Call Transcript
12:40pm, Tuesday, 04'th Aug 2026
IDEXX Laboratories, Inc. (IDXX) Q2 2026 Earnings Call Transcript
IDEXX Laboratories Q2 Earnings Call Highlights
12:05pm, Tuesday, 04'th Aug 2026
IDEXX Laboratories NASDAQ: IDXX reported second-quarter 2026 revenue growth of approximately 10% on a reported basis and 9% organically, driven by companion animal diagnostics, water and livestock, po
Why Is IDEXX Laboratories Stock Gaining Tuesday?
11:39am, Tuesday, 04'th Aug 2026
IDEXX Laboratories, Inc. (NASDAQ:IDXX) stock rose Tuesday after the veterinary diagnostics company reported second-quarter results that topped Wall Street estimates and raised its full-year earnings o
Idexx (IDXX) Reports Q2 Earnings: What Key Metrics Have to Say
10:31am, Tuesday, 04'th Aug 2026
The headline numbers for Idexx (IDXX) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates a
Idexx Laboratories (IDXX) Q2 Earnings and Revenues Top Estimates
08:40am, Tuesday, 04'th Aug 2026
Idexx Laboratories (IDXX) came out with quarterly earnings of $4.27 per share, beating the Zacks Consensus Estimate of $3.95 per share. This compares to earnings of $3.63 per share a year ago.
IDEXX Laboratories Announces Second Quarter Results
06:30am, Tuesday, 04'th Aug 2026
WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced second quarter results. Second Quarter Results The Company rep
Insights Into Idexx (IDXX) Q2: Wall Street Projections for Key Metrics
10:16am, Friday, 31'st Jul 2026
Evaluate the expected performance of Idexx (IDXX) for the quarter ended June 2026, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for b
